Bulletin
Investor Alert

Stryker Corp.

NYS: SYK

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 10, 2020, 5:55 p.m.

SYK
/zigman2/quotes/207664662/composite

$

178.96

Change

+1.07 +0.60%

Volume

Volume 13,932

Quotes are delayed by 20 min

/zigman2/quotes/207664662/composite

Previous close

$ 177.77

$ 177.89

Change

+0.12 +0.07%

Day low

Day high

$176.20

$179.14

Open

52 week low

52 week high

$124.54

$226.30

Open

Company Description

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment...

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Valuation

P/E Current

32.42

P/E Ratio (with extraordinary items)

31.19

P/E Ratio (without extraordinary items)

38.29

Price to Sales Ratio

5.36

Price to Book Ratio

6.14

Price to Cash Flow Ratio

36.40

Enterprise Value to EBITDA

17.94

Enterprise Value to Sales

5.00

Total Debt to Enterprise Value

0.13

Efficiency

Revenue/Employee

372,100.00

Income Per Employee

52,075.00

Receivables Turnover

5.70

Total Asset Turnover

0.52

Liquidity

Current Ratio

2.58

Quick Ratio

1.84

Cash Ratio

1.01

Profitability

Gross Margin

63.03

Operating Margin

22.76

Pretax Margin

17.21

Net Margin

13.99

Return on Assets

7.26

Return on Equity

16.98

Return on Total Capital

14.77

Return on Invested Capital

9.56

Capital Structure

Total Debt to Total Equity

89.62

Total Debt to Total Capital

47.26

Total Debt to Total Assets

38.04

Long-Term Debt to Equity

82.24

Long-Term Debt to Total Capital

43.37

Officers and Executives

Name Age Officer Since Title
Mr. Kevin A. Lobo 53 2011 Group President-Neurotechnology & Spine
Mr. Timothy J. Scannell 54 2001 Group President
Mr. Glenn S. Boehnlein 57 2003 Chief Financial Officer & Vice President
Mr. Michael Panos - - President-North America
Ms. Bronwen R. Taylor - 2000 Vice President-Internal Audit & Compliance

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/15/2020 Glenn S. Boehnlein
VP, Chief Financial Officer
10,351   Disposition at $185.24 per share. 1,917,419
05/29/2020 Allan C. Golston
Director
7,299   Disposition at $193.23 per share. 1,410,385
05/29/2020 Allan C. Golston
Director
1,809   Derivative/Non-derivative trans. at $195.35 per share. 353,388
05/29/2020 Allan C. Golston
Director
1,357   Derivative/Non-derivative trans. at $195.35 per share. 265,089
05/29/2020 Allan C. Golston
Director
5,520   Derivative/Non-derivative trans. at $64.01 per share. 353,335
05/29/2020 Allan C. Golston
Director
4,945   Derivative/Non-derivative trans. at $53.6 per share. 265,052
05/20/2020 Srikant T. Madhav Datar
Director
400   Disposition at $191.25 per share. 76,500
05/19/2020 Srikant T. Madhav Datar
Director
350   Disposition at $191.2 per share. 66,920
05/19/2020 Srikant T. Madhav Datar
Director
385   Derivative/Non-derivative trans. at $191.92 per share. 73,889
05/19/2020 Srikant T. Madhav Datar
Director
1,235   Derivative/Non-derivative trans. at $59.7 per share. 73,729
05/08/2020 Srikant T. Madhav Datar
Director
200   Disposition at $194.32 per share. 38,864
05/07/2020 Srikant T. Madhav Datar
Director
200   Disposition at $190.92 per share. 38,184
05/07/2020 Srikant T. Madhav Datar
Director
300   Disposition at $189.37 per share. 56,811
05/07/2020 Katherine A. Owen
VP, Strategy and IR
3,121   Disposition at $190.81 per share. 595,518
05/06/2020 Srikant T. Madhav Datar
Director
200   Disposition at $186.01 per share. 37,202
05/06/2020 Srikant T. Madhav Datar
Director
795   Derivative/Non-derivative trans. at $187.93 per share. 149,404
05/06/2020 Katherine A. Owen
VP, Strategy and IR
4,436   Derivative/Non-derivative trans. at $187.93 per share. 833,657
05/06/2020 Katherine A. Owen
VP, Strategy and IR
2,983   Derivative/Non-derivative trans. at $187.93 per share. 560,595
05/06/2020 Katherine A. Owen
VP, Strategy and IR
2,443   Derivative/Non-derivative trans. at $187.93 per share. 459,112
05/06/2020 Srikant T. Madhav Datar
Director
2,500   Derivative/Non-derivative trans. at $59.7 per share. 149,250
05/06/2020 Katherine A. Owen
VP, Strategy and IR
5,500   Derivative/Non-derivative trans. at $122.51 per share. 673,805
05/06/2020 Katherine A. Owen
VP, Strategy and IR
4,087   Derivative/Non-derivative trans. at $96.64 per share. 394,967
05/06/2020 Katherine A. Owen
VP, Strategy and IR
3,396   Derivative/Non-derivative trans. at $93.06 per share. 316,031
05/05/2020 Katherine A. Owen
VP, Strategy and IR
9,149   Disposition at $186.79 per share. 1,708,941
05/01/2020 Ronda E. Stryker
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Srikant T. Madhav Datar
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Roch F. Doliveux
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Louise L. Francesconi
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Viju S. Menon
Group President
3,443   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Mary K. Brainerd
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Rajeev Suri
Director
937   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Viju S. Menon
Group President
1,344   Derivative/Non-derivative trans. at $186.43 per share. 250,561
04/30/2020 Roch F. Doliveux
Director
51   Acquisition at $190.08 per share. 9,694
04/30/2020 Robert Fletcher
VP, Chief Legal Officer
4,272   Derivative/Non-derivative trans. at $0 per share. 0
04/30/2020 Robert Fletcher
VP, Chief Legal Officer
1,394   Derivative/Non-derivative trans. at $192.68 per share. 268,595
/news/latest/company/us/syk

MarketWatch News on SYK

  1. Stryker downgraded to buy from strong buy at CFRA

    2:32 p.m. May 28, 2020

    - Tomi Kilgore

  2. Stryker stock price target cut to $162 from $247 at SVB Leerink

    8:53 a.m. March 25, 2020

    - Tomi Kilgore

  3. Stryker stock price target cut to $145 from $250 at Stifel Nicolaus

    7:49 a.m. March 24, 2020

    - Tomi Kilgore

  4. Stryker started at hold with $217 stock price target at SunTrust RH

    11:08 a.m. Jan. 8, 2020

    - Tomi Kilgore

  5. Mastercard and 4 More Companies That Are Raising Their Dividends

    9:00 a.m. Dec. 7, 2019

    - Barron's Online

  6. Stryker raises quarterly dividend by 11%

    4:03 p.m. Dec. 4, 2019

    - Tomi Kilgore

  7. Medical-Device Company Stryker Buys Smaller Rival Wright

    11:31 a.m. Nov. 4, 2019

    - Barron's Online

  8. Stryker's stock turns lower, falls 3.2% after Wright Medical buyout deal

    9:31 a.m. Nov. 4, 2019

    - Tomi Kilgore

  9. Wright Medical's stock rockets 34% premarket after Stryker buyout deal, Stryker shares up 0.1%

    8:05 a.m. Nov. 4, 2019

    - Tomi Kilgore

  10. Styker to pay $30.75 a share in cash for Wright Medical, a 40% premium

    8:04 a.m. Nov. 4, 2019

    - Tomi Kilgore

  11. Stryker agrees to acquire Wright Medical in deal with total enterprise value of about $5.4 bln

    8:02 a.m. Nov. 4, 2019

    - Ciara Linnane

  12. Loading more headlines...
/news/nonmarketwatch/company/us/syk

Other News on SYK

  1. Buy And Hold Vs. Rotational Strategy: June 2020 Update

    4:29 p.m. July 7, 2020

    - Seeking Alpha

  2. Top 10 Healthcare Stocks For Dividend Growth And Income

    9:01 a.m. July 6, 2020

    - Seeking Alpha

  3. The Top 7 Healthcare Stocks You Should Be Watching

    11:17 a.m. June 30, 2020

    - InvestorPlace.com

  4. Stocks I Bought On The Dip: Stryker Corporation

    11:33 p.m. June 21, 2020

    - Seeking Alpha

  5. Dividend Champion And Contender Highlights: Week Of June 21

    1:24 p.m. June 20, 2020

    - Seeking Alpha

  6. Buy And Hold Vs. Rotational Strategy: May 2020 Update

    2:36 p.m. June 2, 2020

    - Seeking Alpha

  7. Why Is Stryker (SYK) Up 5% Since Last Earnings Report?

    11:31 a.m. May 30, 2020

    - Zacks.com

  8. IPO Update: Inari Medical Proposes IPO Terms

    2:15 p.m. May 18, 2020

    - Seeking Alpha

  9. Tracking Yacktman Asset Management Portfolio - Q1 2020 Update

    5:55 a.m. May 12, 2020

    - Seeking Alpha

  10. Loading more headlines...

At a Glance

Stryker Corp.

2825 Airview Boulevard

Kalamazoo, Michigan 49002

Phone

1 2693852600

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$14.88B

Net Income

$2.08B

2019 Sales Growth

9.4%

Employees

40,000

/news/pressrelease/company/us/syk

Press Releases on SYK

  1. Cervical Disc Replacement Market Size Forecast to Reach $3.82 Billion by 2025

    8:46 a.m. Today

    - The Express Wire

  2. Global Durable Medical Equipment Market Size to exceed $ 246 Bn by 2026

    9:28 a.m. July 10, 2020

    - Market Insight Reports

  3. Loading more headlines...
Link to MarketWatch's Slice.